University Research Co., LLC, Bethesda, MD 20814, USA.
Int J Gynaecol Obstet. 2012 Jun;117(3):278-82. doi: 10.1016/j.ijgo.2012.01.017. Epub 2012 Apr 6.
To analyze the Ecuadorian experience regarding the adoption, scale-up, and institutionalization of active management of the third stage of labor (AMTSL) for prevention of postpartum hemorrhage via continuous quality improvement (CQI) processes.
Average AMTSL implementation rates for women with vaginal deliveries were compared using unweighted provincial aggregate data from facilities participating in 3 phases of AMTSL programming. Months taken to implement AMTSL at 80% or more and 90% or more compliance were compared across phases.
Rate of oxytocin administration during the first 3 months was 5.0% in phase 1, 9.8% in phase 2, and 72.2% in phase 3 (P≤0.001 vs phases 1 and 2). The average number of months provinces took to increase oxytocin administration to 80% or more and 90% or in more women with vaginal deliveries was, respectively, 21.6±18.7 and 30.6±16.4 in phase 1, 23.5±15.1 and 30.1±14.9 in phase 2, and 4.7±4.9 (P≤0.01 vs phase 1; P≤0.001 vs phase 2) and 4.0±3.4 (P≤0.001 vs phases 1 and 2) in phase 3. By December 2009, AMTSL implementation was sustained at 90% or more in all provinces.
CQI processes identified resistance and operational barriers, and developed mechanisms to overcome them.
分析厄瓜多尔在通过持续质量改进(CQI)过程采用、扩大和制度化第三产程积极管理(AMTSL)以预防产后出血方面的经验。
使用参与 AMTSL 编程 3 个阶段的设施的省级汇总数据,比较阴道分娩妇女的平均 AMTSL 实施率。比较各阶段达到 80%或以上和 90%或以上依从率所花费的时间。
第一阶段缩宫素使用率为 5.0%,第二阶段为 9.8%,第三阶段为 72.2%(P≤0.001 与前两个阶段比较)。各省将催产素用于 80%或以上妇女和 90%或以上妇女的平均时间分别为第一阶段 21.6±18.7 个月和 30.6±16.4 个月,第二阶段为 23.5±15.1 个月和 30.1±14.9 个月,第三阶段为 4.7±4.9(P≤0.01 与第一阶段比较;P≤0.001 与第二阶段比较)和 4.0±3.4(P≤0.001 与前两个阶段比较)。到 2009 年 12 月,所有省份的 AMTSL 实施率均维持在 90%或以上。
CQI 流程发现了阻力和操作障碍,并制定了克服这些障碍的机制。